PD-126055 free acid
Title | Journal |
---|---|
Development of EMA401 as an orally-administered, highly-selective angiotensin II type 2 receptor antagonist for the treatment of neuropathic pain. | Journal of the peripheral nervous system : JPNS 20141001 |
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial. | Lancet (London, England) 20140510 |
Angiotensin II: from blood pressure to pain control. | Lancet (London, England) 20140510 |
Small molecule angiotensin II type 2 receptor (AT₂R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats. | Pain medicine (Malden, Mass.) 20130501 |
Intraneuronal angiotensinergic system in rat and human dorsal root ganglia. | Regulatory peptides 20100608 |
Estrogen elicits dorsal root ganglion axon sprouting via a renin-angiotensin system. | Endocrinology 20080701 |
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. | Journal of medicinal chemistry 19960202 |